Measuring irritable bowel syndrome patient‐reported outcomes with an abdominal pain numeric rating scale
Open Access
- 2 November 2009
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 30 (11-12), 1159-1170
- https://doi.org/10.1111/j.1365-2036.2009.04144.x
Abstract
Background Controversy exists on how to measure patient‐reported outcomes in irritable bowel syndrome (IBS) clinical trials effectively. Pain numeric rating scales (NRS) are widely used in the non‐IBS pain literature. The Food and Drug Administration has proposed using the NRS in IBS. Aim To test the psychometrics of an abdominal pain NRS in IBS. Methods We analysed data from a longitudinal cohort of Rome III IBS subjects. At entry, subjects completed a 10‐point NRS, bowel symptoms, IBS severity measurements (IBS‐SSS, FBDSI), health‐related quality of life indices (IBS‐QOL, EQ5D), and the Worker Productivity Activity Index (WPAI). We repeated assessments at 3 months along with a response scale to calculate the minimal clinically important difference. Results There were 277 subjects (82% women; age = 42 ± 15) at baseline and 90 at 3 months. The NRS correlated cross‐sectionally with IBS‐SSS (r = 0.60; P < 0.0011), FBDSI (r = 0.49; P < 0.0001), IBS‐QOL (r = 0.43; P < 0.0001), EQ5D (r = 0.48; P < 0.0001), presenteeism (r = 0.39; P < 0.0001), absenteeism (r = 0.17; P = 0.04) and distension (r = 0.46; P < 0.0001), but not stool frequency or form. The minimal clinically important difference was 2.2 points, correlating with a 29.5% reduction over time. Conclusions An abdominal pain NRS exhibits excellent validity and can be readily interpreted with a minimal clinically important difference in patients with IBS. These data support the use of the NRS in IBS clinical trials.Keywords
This publication has 35 references indexed in Scilit:
- 422 Impact of Baseline Severity On the Performance of IBS Clinical Trial Endpoints: Results of the ROME Foundation Endpoints Working Group Meta-AnalysisGastroenterology, 2009
- Irritable Bowel Syndrome: More Than Abdominal Pain and Bowel Habit AbnormalitiesClinical Gastroenterology and Hepatology, 2009
- Predictors of Patient-Assessed Illness Severity in Irritable Bowel SyndromeThe American Journal of Gastroenterology, 2008
- Self-Administered Cognitive Behavior Therapy for Moderate to Severe Irritable Bowel Syndrome: Clinical Efficacy, Tolerability, FeasibilityClinical Gastroenterology and Hepatology, 2008
- 155 Predictors of Work Productivity in Irritable Bowel Syndrome (IBS): Results from the Proof CohortGastroenterology, 2008
- Clinical trial: dextofisopam in the treatment of patients with diarrhoea‐predominant or alternating irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 2007
- Measuring Health-Related Quality of Life in Patients With Irritable Bowel Syndrome: Can Less Be More?Psychosomatic Medicine, 2006
- Methods to Explain the Clinical Significance of Health Status MeasuresMayo Clinic Proceedings, 2002
- Functional bowel disordersDigestive Diseases and Sciences, 1995
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990